Navigation Links
MimiVax presenting at Biotech Showcase; Attending JP Morgan 2017 Healthcare Conference

MimiVax to present at Biotech Showcase; attending JP Morgan 2017 Healthcare Conference

MimiVax, LLC will be presenting at the 9th Annual Biotech Showcase Conference in San Francisco, Jan 9-12, 2017. The company will provide an overview and update on its immuno-oncology programs. Company will be highlighting its lead program SurVaxM that is in ongoing Phase II clinical study in patients with newly diagnosed glioblastoma. Besides its late stage SurVaxM program, company will share for the first time its preclinical pipeline of assets. This includes monoclonal antibody (Sur-MAb) and CAR-T/Adaptive T-cell therapy program. The 9th Annual Biotech Showcase Conference presentation will be on Tuesday January 10th at 10:15AM, at the Hilton San Francisco.

MimiVax will also be in attendance for The J.P. Morgan 35th Annual Healthcare Conference, taking place between Jan. 9 – 13, 2017 at the Westin St. Francis Hotel. During the event, MimiVax executives (CSO; Michael Ciesielski, PhD and VP, BD; Anil Goyal, PhD) will be available for meetings to discuss investment and pharmaceutical partnership opportunities.

2017 Biotech Showcase Conference:
Presenting, Tuesday, Jan. 10, 2017, 10:15 AM;
Hilton San Francisco Union Square, Room 9 Ballroom Level, San Francisco, CA

JP Morgan 2017 Healthcare Conference:
Monday - Friday, Jan. 9 - 13, 2017; Westin St. Francis Hotel, San Francisco, CA

About MimiVax: MimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutics and targeted therapies for the treatment of cancer. Our proprietary product portfolio is based on technology licensed from Roswell Park Cancer Institute that targets survivin, a cell-survival protein that is present in most cancers and rarely detectable in normal tissue. Our therapies are designed to stimulate immune responses to control tumor growth and recurrence.

About SurVaxM: SurVaxM, our lead immunotherapeutic candidate, has demonstrated safety and tolerability and strong efficacy signal in a Phase I study in patients with malignant gliomas (brain tumors). SurVaxM is an “engineered immune activating novel/neo antigen” applicable across most histologies. SurVaxM’s single long peptide (SLP) is engineered to be activating to mid-affinity T cell receptors. Mid-affinity T cell receptors have been shown to be critical for sustained T effector activation and durable T cell responses.   

SurVaxM is currently being evaluated in a Phase II clinical trial in adults with newly diagnosed glioblastoma, and a Phase I clinical trial in combination with REVLIMID® (lenalidomide) as a maintenance therapy for adults with multiple myeloma (a form of blood cancer).

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. 2017 iaedp™ Symposium Continues Tradition of Presenting the Latest in Eating Disorder Treatment with Top Professionals in U.S.
2. Presenting Channeled Messages for Higher Spiritual Awareness
3. HRA - Healthcare Research & Analytics Executives Presenting at PBIRG 55th Annual General Meeting
4. Florida Hospital Clinches the Presenting Sponsor of the 2016 Tampa Bay Lightning Playoffs and Stanley Cup Finals for the Second Year in a Row
5. Christian Bogner, MD Presenting At The Holistic Cannabis Summit
6. The Oncology Institute of Hope & Innovation Partners with Wellpoint and Stanford in Presenting a Tri-Part Research Collaboration at the 2016 ASCO Quality Care Symposium
7. Clearshark Named Presenting Sponsor of 2016 Iron Girl Columbia Triathlon
8. Four-Week Countdown: 2016 iaedp™ Symposium Continues Tradition of Presenting the Latest in Eating Disorder Treatment with the Country’s Top Professionals
9. Dr. Zaidan Presenting An Educational Seminar On Endometriosis
10. Care Logistics Presenting at the Conference of Metropolitan & Regional Hospital Associations Annual Meeting
11. NATA and the PATS Join Congressman Ryan Costello in Presenting the NATA Safe Sports School Award to Spring-Ford High School
Post Your Comments:
(Date:5/26/2020)... , ... May 26, 2020 ... ... previously unknown mechanism through which certain infections can impact the brain causing ... Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric ...
(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, ... advocate Joan Price have just received the 2020 AASECT Audio Visual Award for jessica ... was the first of its kind to feature non-actors in its demonstrations and narratives ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... CRC’s Guide to Coordinating Clinical Research, CenterWatch eLearning , ... CRC Trainer: An Interactive Companion to the CRC’s Guide to Coordinating Clinical ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... industry leader in cancer biomarker assays, announced today that Cigna has added ROMA® ... is a global health service company dedicated to improving the health, well-being, and ...
(Date:5/21/2020)... ... May 21, 2020 , ... Friends of Lisa Campbell, announce that Lisa Campbell, ... Planned Parenthood Southeast Advocates (PPSEA). PPSEA educates and lobbies on behalf of ... range of reproductive health care. PPSEA educates and lobbies on behalf of women’s health ...
Breaking Medicine News(10 mins):
(Date:5/27/2020)... (PRWEB) , ... May 27, 2020 , ... Hemp Health One’s Giving Away Free CBD ... products for the next 60 days. The company is hosting the daily giveaway contest on ... by following Hemp Health One’s Instagram page or Hemp Health One’s Facebook page. Then, like ...
(Date:5/26/2020)... ... May 26, 2020 , ... Coppe Healthcare Solutions (Coppe ... the laboratory division of the Open Medicine Institute based in San Francisco Bay ... Knox, the Virologist who previously co-founded what is now Viracor-Eurofins in the year ...
(Date:5/25/2020)... , ... May 25, 2020 , ... AltMed Florida ... continues its statewide expansion with a three-day, Memorial Day Opening, starting Monday May 25 ... Springs. , During the opening, staggered over three-days for crowd mitigation, all licensed Florida ...
Breaking Medicine Technology: